Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.
Title | Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Polyzos, S. A., Kountouras J., Anastasilakis A. D., Makras P., Hawa G., Sonnleitner L., Missbichler A., Doulberis M., Katsinelos P., & Terpos E. |
Journal | Hormones (Athens) |
Volume | 17 |
Issue | 4 |
Pagination | 573-579 |
Date Published | 2018 Dec |
ISSN | 2520-8721 |
Keywords | Carrier Proteins, Case-Control Studies, Drug Therapy, Combination, Humans, Mineralocorticoid Receptor Antagonists, Non-alcoholic Fatty Liver Disease, Spironolactone, Vitamin E |
Abstract | AIM: The evaluation of (a) noggin levels in patients with simple steatosis (SS) vs. nonalcoholic steatohepatitis (NASH) vs. controls, and (b) the effect of combined spironolactone plus vitamin E vs. vitamin E monotherapy on noggin levels in biopsy-proven patients with nonalcoholic fatty liver disease (NAFLD). |
DOI | 10.1007/s42000-018-0083-8 |
Alternate Journal | Hormones (Athens) |
PubMed ID | 30467685 |